Liver Specialist I Institute of Gastrosciences I Apollo Hospitals I Via PGIMER Chandigarh &SGPGIMS Lucknow I Executive Editor https://xitter.cf/t.co/ryV6DeHeGJ
Kolkata, India
Joined April 2020
- Tweets1.5K
- Following521
- Followers1.8K
- Likes5.8K
Pinned Tweet
Humbled to be awarded the OP Memorial Rising Star Award at ISGCON 2025. Moments like these rekindle why the journey is worth it.
Grateful to all my mentors, colleagues and patients
🥂 to @AnandVKulkarni2 for winning the SR Nayak Researcher Award
🎗️Award twinning mode on✨
Akash Roy retweeted
Many congratulations Naveen @naveendandia
Keep it up.
Best wishes.
Akash Roy retweeted
This year @AASLDtweets #TLM26 Do join us for the ACLF sessions. @ruben_hernaez @JasmohanBajaj @CLEARED_liver @APASL_AARC @ef_clif @AASLDPresident @LiverFellow @RoyAHep @drnipunverma @JustSagnik @drshalimar @ebtapper @RajivJalan1 #LiverX
Akash Roy retweeted
📑 L-Taurine for #Fatigue in Decompensated Cirrhosis⁉️
❎ Negative trial overall
⭐️ BUT, patients without anemia🩸 had a large ⬇️ in fatigue 😴, while those with anemia did not❕
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Multicentre study of 966 patients hospitalised with acute decompensation of cirrhosis highlights distinct clinical phenotypes.
🔹 First presentation: higher bilirubin
🔹 Prior decompensation: more encephalopathy, shock and renal dysfunction
sciencedirect.com/science/ar… – at Kolkata, India
🔹 Interestingly, 25.9% did not meet biochemical liver-failure thresholds evaluated, yet had 33.6% mortality.
🔹 Infection, encephalopathy and extrahepatic organ dysfunction were important markers of risk. – at Kolkata, India
@AnandVKulkarni2 @karanbjmc93 @DrArunKValsan @drnipunverma @ajay_duseja @drsuniltaneja @docMPK @giri_gutnliver – at Kolkata, India
Akash Roy retweeted
#liverTwitter Proud to see the CORE database we built already generating meaningful insights. Our latest study uses CORE (23 centres now) to model the natural hx of decompensation, an exciting first step toward answering important clinical questions.
journals.lww.com/hepcomm/ful…
Akash Roy retweeted
Humbled to have achieved it...
Need to thank a lot of people in helping me do this..
My family @RitambhraN
Institute @pgichd, @dpgi_chandigarh
My Mentors..
Department @HepatologyPGI
Collaborators.
Mentees.
My friends, colleagues, research staff and patients..
Akash Roy retweeted
AI-generated slides have taken over every conference.😴
Boxes inside boxes, microscopic text, arrows connecting everything to everything else
The message is hidden deeper than a pelvic node!
Quite a turn-off.
We need a pre-conference workshop just to read the slides.
Akash Roy retweeted
#LiverTwitter Happy to share our latest paper from the #CORE consortium, an Asia Pacific led initiative to understand compensated liver cirrhosis. Our latest paper explore how statin reduces the risk of hepatic decompensation and LRE @hepinternation1.
link.springer.com/article/10…
Akash Roy retweeted
How do Type A (first timers) and B (prior decomp) ACLF behave?
First-timers, i.e., type A: alcohol and viral-> liver failure recovery possible (have treatment).
Prior decomp (type B, usually MASLD and ALD) - high mortality if they satisfy liver failure criteria.
Type B without liver failure (mostly MASLD ~25% of total population) - mortality is 30%+ and driven by infection, HE, AKI. sciencedirect.com/science/ar…
@JasmohanBajaj @Florent_Artru @ef_clif @APASL_AARC @CLEARED_liver @ Prof. Choudhury, @ruben_hernaez @drnipunverma @AsraniSumeet @RoyAHep @DrArunKValsan @karanbjmc93 @dean_karvellas #ACLF #Kyoto #liverx
Akash Roy retweeted
Living-Related Donor Liver Transplantation for Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
👇🏽 jcehepatology.com/article/S0…
Akash Roy retweeted
📑 Who is most likely to fall in #cirrhosis⁉️
Strongest risks:
🚨Prior Fall
🚨Frailty
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Akash Roy retweeted
I am proud to share that for the SIXTH consecutive year, my name has appeared in the list of the world’s top 2% scientists (published in October 2026 by researchers from Stanford University, USA).
From India, I am ranked 17th in the field of Gastroenterology and Hepatology.
Akash Roy retweeted
Honoured to receive Promising Academic Achiever AWARD at World Congress of Gastroenterology 2026, New Delhi. 🏆🌍
It was awarded by INMA. Grateful to my family members and everyone who has been part of this journey especially Uday C Ghoshal and Prof Sanjeev Sachdeva sir.
🤖 Made with AI
Akash Roy retweeted
Beyond the rebound and the calculator: dynamic prognostication after plasma exchange in pediatric acute liver failure
Checkout @drnipunverma @ajay_duseja
👇🏽 jcehepatology.com/article/S0…
Akash Roy retweeted
Acute Kidney Disease and Clinical Outcomes in Stable Outpatients with Decompensated Cirrhosis
Check out at @JCEH_Hepatology
👇🏽 jcehepatology.com/article/S0…
Akash Roy retweeted
15% with LSM above 15 decompensate over 4 years.
LSM of 28 high chance of decomp.
Diabetes- high chance of death after 1st decomp.
ALD- overall high decomp rate (etiology control difficult- chance of relapse!)
HBV- low (etiology treatable with drugs)
Don’t ignore LSM. #livertwitter #liverx
The core consortium is a group of like minded individuals created at AASLD TLM 2025. @DrMarkMuthiah @ChengHanNg @RoyAHep Dr Takahashi @JimmyLaiCT @DrHuangDQ @KarnJUVE Dr Ken Liu @Apichatka @kumarrahul0204
What the future has in store your patient with a liver stiffness measure of 15+
A landmark study in @HepCommJournal journals.lww.com/hepcomm/ful…
Rate of decompensation
Low risk in hep b
Higher risk with ALD
